GINGER BROOKS: Open Payments
NPI 1881998078 · GREENVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,236 in 57 payments from 24 companies in 2025. Trend: 2023 $339 · 2024 $682 · 2025 $2,236
Long term medical supply or device loan: $1,196Food & beverage: $941Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $1,258 |
| ABBVIE INC. | 2 | $122 |
| Tempus AI, Inc | 5 | $116 |
| E.R. Squibb & Sons, L.L.C. | 5 | $96 |
| PFIZER INC. | 4 | $73 |
| Merck Sharp & Dohme LLC | 3 | $69 |
| Caris MPI, Inc. | 2 | $51 |
| Genentech USA, Inc. | 2 | $48 |
| Karyopharm Therapeutics Inc. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
Products named: KISQALI, XT CDX, IMBRUVICA, OPDIVO, KEYTRUDA, MI CANCER SEEK, XPOVIO, Nubeqa.
Industry payments across TX — which companies pay providers there.
